Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 507747 | NSE Symbol : TTKHLTCARE | ISIN : INE910C01018 | Industry : Diversified - Medium / Small |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
21-Mar-2025	21-Mar-2025	Change in Directors	Outcome of Board Meeting - March 21, 2025.
09-Jan-2025	24-Jan-2025	Quarterly Results	Quarterly Results TTK HEALTHCARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/01/2025 ,inter alia, to consider and approve The meeting of the Board of Directors of the Company is scheduled on 24/01/2025. (As Per BSE Announcement Dated on: 09/01/2025) Outcome of the Board Meeting held on January 24, 2025. (As Per BSE Announcement dated on 24.01.2025)
14-Oct-2024	25-Oct-2024	Quarterly Results	TTK HEALTHCARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/10/2024 inter alia to consider and approve Board Meeting Intimation - October 25 2024 Unaudited Financial Results along with the Limited Review Report for the Second Quarter and Half-Year ended September 30, 2024 Outcome of the Board Meeting - Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 (As Per BSE Announcement Dated on 25.10.2024)
16-Oct-2024	16-Oct-2024	Change in Directors	Outcome of the Board Meeting - Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015
10-Jul-2024	02-Aug-2024	Quarterly Results	TTK HEALTHCARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/08/2024 inter alia to consider and approve Meeting of the Board of Directors of the Company is scheduled to be held on Friday August 02 2024 inter alia to consider and approve the Unaudited Financial Results of the Company for the First Quarter ended June 30 2024. Unaudited Financial Results along with Limited Review Report for the First Quarter ended June 30, 2024 Outcome of the Board Meeting - Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 Outcome of the Board Meeting - Disclosure under Regulations 30 of SEBI (LODR) Regulations, 2015 (As Per BSE Announcement Dated on 02.08.2024)
02-May-2024	24-May-2024	Final Dividend	TTK HEALTHCARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 24/05/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday the May 24 2024 inter alia (i) to consider and approve the Audited Financial Results of the Company for the year ended March 31 2024; and (ii) to consider and recommend dividend if any for the financial year 2023-24. Outcome of the Board Meeting - Disclosure under Regulation 30 of SEBI (LODR) Regulations, 2015 (As Per BSE Announcement Dated on 24/05/2024) Announcement under Regulation 30 (LODR) - Newspaper Publication (As Per BSE Announcement Dated on 25/05/2024)
02-Jan-2024	02-Feb-2024	Quarterly Results	TTK HEALTHCARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2024 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday the 2nd February 2024 inter alia to consider and approve the Unaudited Financial Results of the Company for the Third Quarter ended 31st December 2023 Unaudited Financial Results for the Third Quarter and Period ended 31st December, 2023 along with the Limited Review Report. Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015 - Reappointment of Directors, effective 1st June, 2024, subject to the approval of the Shareholders. (1) Unaudited Financial Results for the Third Quarter and Period ended 31st December, 2023 along with Limited Review Report; (2) Reappointment of Directors; (3) Postal Ballot Process for obtaining the approval of the Shareholders for the reappointment of Directors; and (4) Appointment of Internal Auditors and Tax Auditor. Announcement under Regulation 30 of SEBI (LODR) Regulations, 2015 - Intimation relating to conducting of the Postal Ballot Process and the Calendar of Events. (As Per BSE Announcement Dated on 02/02/2024)
04-Oct-2023	03-Nov-2023	Quarterly Results	TTK HEALTHCARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 03/11/2023 inter alia to consider and approve The meeting of the Board of Directors of the Company is scheduled on 03/11/2023 inter alia to consider and approve the Unaudited Financial Statements for the second Quarter ended 30/09/2023. Disclosure under Regulation 30 - Unaudited Financial Results along with Limited Review Report for the Second Quarter and Half-Year ended 30th September, 2023. (As Per BSE Announcement Dated on 03/11/2023)
14-Jul-2023	01-Aug-2023	Quarterly Results	TTK HEALTHCARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/08/2023 inter alia to consider and approve Meeting of the Board of Directors of the Company to be held on August 01 2023 inter alia to consider and approve the Unaudited Financial Results of the Company for the First Quarter ended 30th June 2023. Disclosure under Regulation 30 - Unaudited Financial Results along with Limited Review Report for the First Quarter ended June 30, 2023. Disclosure under Regulation 30 - Unaudited Financial Results along with Limited Review Report for the First Quarter ended June 30, 2023 (As per BSE Announcement Dated on 01/08/2023)
02-May-2023	23-May-2023	Accounts	TTK HEALTHCARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2023 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Tuesday the 23rd May 2023 inter alia (i) to consider and approve the Audited Financial Results of the Company for the year ended 31st March 2023; and (ii) to consider and recommend dividend if any for the financial year 2022-23. Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we would like to inform you that the Board of Directors in their meeting held today, inter alia considered and approved / recommended the following: (i) Dividend of Rs.10/- per Equity Share of Rs.10/- each (100%), for the financial year ended 31st March, 2023 which shall be paid / despatched within 21 days from the date of AGM, subject to the approval of the Shareholders; (ii) The 65th Annual General Meeting of the Company has been scheduled to be held on Tuesday, the 25th July, 2023, through Video Conferencing / Other Audio Visual Means (VC / OAVM); (iii) We enclose a brief highlights of the Audited Financial Statements for the year ended 31st March, 2023. Pursuant to the provisions of Regulations 30 & 33 of the SEBI (LODR) Regulations, 2015, we are sending herewith the following documents, duly approved and taken on record by the Board of Directors in their meeting held today [(i.e.) 23rd May, 2023]: (i) Audited Financial Results for the Fourth Quarter and Year ended 31st March, 2023; (ii) Statutory Auditors' Report with unmodified opinion; and (iii) Declaration by the Executive Chairman (CEO) that the Audit Report is with unmodified opinion 65th Annual General Meeting of the Company has been scheduled to be held on Tuesday, the 25th July, 2023, through Video Conferencing / Other Audio Visual Means (VC / OAVM). (As Per BSE Announcement Dated on 23.05.2023)
05-Apr-2023	20-Apr-2023	Delisting of Shares	TTK HEALTHCARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/04/2023 inter alia to consider and approve Prior intimation in accordance with Regulation 29 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015 as amended ('SEBI Listing Regulations') and the Securities and Exchange Board of India (Delisting of Equity Shares) Regulations 2021 ('SEBI Delisting Regulations') with respect to the meeting of Board of Directors of TTK Healthcare Limited ('Company') to be held on 20th April 2023 to consider the proposal for voluntary delisting of the Equity Shares of the Company having the face value of INR 10/- per share ('Equity Shares') ('Delisting Proposal/ Delisting Offer) Voluntary Delisting of the Equity Shares of the Company from BSE Limited (BSE) and National Stock Exchange of India Limited (NSE) by the Acquirers (Mr T T Jagannathan, Mr T T Raghunathan and M/s T T Krishnamachari & Co., represented by its Partners - Mr T T Jagannathan, Mr T T Raghunathan, Mrs Latha Jagannathan, Mrs Bhanu Raghunathan, Mr T T Mukund, Mr T T Lakshman, Mr T T Venkatesh and Mr T T Sriram), in accordance with the SEBI (Delisting of Equity Shares) Regulations, 2021. and to obtain the approval of the Shareholders by means of a Special Resolution through Postal Ballot Process by way of e-Voting Voluntary Delisting of the Equity Shares of the Company from BSE Limited (BSE) and National Stock Exchange of India Limited (NSE) by the Acquirers (Mr T T Jagannathan, Mr T T Raghunathan and M/s T T Krishnamachari & Co., represented by its Partners - Mr T T Jagannathan, Mr T T Raghunathan, Mrs Latha Jagannathan, Mrs Bhanu Raghunathan, Mr T T Mukund, Mr T T Lakshman, Mr T T Venkatesh and Mr T T Sriram), in accordance with the SEBI (Delisting of Equity Shares) Regulations, 2021. and to obtain the approval of the Shareholders by means of a Special Resolution through Postal Ballot Process by way of e-Voting (As Per BSE Announcement Dated on 20.04.2023) Board took the following decisions:- (a) The Due Diligence Report dated 20rh April, 2023 ('Report') submitted by M/s A K Jain & Associates, Practicing Company Secrelaries, a Peer Review Company Secrelary Firm, in terms of Regulation '10(3) of SEBI Delisting Regulations, was reviewed and taken on record by the Board. (b) Further, the Audit Report dated 20th April, 2023 submitted by Mr Balu Sridhar, Partner, M/s A K Jain & Associates, Practicing Company Secrelary, (Membership No.5869, C.P. No.3550 & Peer Review Certillcate No.1201l2O21) as 'Peer Review Company Secretary', in accordance with Regulation 76 of the SEBI (Depositories and Participants) Regulations,2018 read with Regulation 12(2) ofthe SEBI Delisting Regulations, in respect to the Equity Shares proposed to be delisted, covering a period of 6 months prior to the date of the Board Meeling, was taken on record by the Board. (c) The Board took on remrd the letter dated April, 2023 received from the Acquire(s) informing the Company thal the Floor Price of the delisting offer is INR 1051.3'l per Equity Share, which is determined in accordance with Regulation 20(2) of the SEBI Delisting Regulations read with Regulation 8 of the Securities and Exchange Board of lndia (Substantial Acquisition of Shares and Takeovers) Regulations. 201 1 . ln support of the aforesaid, the letter was accompanied by a certiricate dated 19h Ap(i1,2023 issued by M/s Aiyar & Co., Chartered Accountants. (d) The Delisting Proposal was approved, in accordance with Regulation 10 ofthe SEBI Delisting Regulations, after discussing and considering various factors including the Report on Floor Price. (e) Based on the information available wilh Company and afterlaking on record the Report, the Board in accordance with Regulation 10(4) of the SEBI Delisting Regulations, certified that: (i) the Company is in mmpliance with the applicable provisions of securities lawsi (iD the Acquirers and its related entities are in compliance with the applicable provisions ofsecurities laws in terms of the report including compliance with Regulation 4(5) of the SEBI Delisting Regulations; and (iiD the Delisting Proposal is in the interest ofthe shareholders of the Company (As Per BSE Bulletin Dated on 20.04.2023)
27-Dec-2022	07-Feb-2023	Quarterly Results	TTK HEALTHCARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2023 inter alia to consider and approve the Unaudited Financial Results of the Company for the Third Quarter ending 31st December 2022. Unaudited Financial Results along with Limited Review Report for the Third Quarter and Period ended 31st December, 2022 Unaudited Financial Results along with Limited Review Report for the Third Quarter and Period ended 31st December, 2022. (As Per BSE Announcement Dated on 07.02.2023)
14-Oct-2022	28-Oct-2022	Quarterly Results	TTK HEALTHCARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/10/2022 inter alia to consider and approve Pursuant to Regulation 29 of the SEBI (LODR) Regulations 2015 we hereby inform you that a meeting of the Board of Directors of the Company is scheduled to be held on Friday the 28th October 2022 inter alia to consider and approve the Unaudited Financial Results of the Company for the Second Quarter ended 30th September 2022. Unaudited Financial Results along with the Limited Review Report from the Statutory Auditors of the Company, for the Second Quarter and Half-Year ended 30th September, 2022, duly reviewed by the Audit Committee at their meeting held yesterday (i.e.) on 27th October, 2022 and approved by the Board of Directors of the Company at their Meeting held today. (As Per BSE Announcement Dated on 28.10.2022) We hereby inform you that the Unaudited Financial Results, for the Second Quarter and Half-Year ended 30th September, 2022 was published in the Newspapers viz., Business Standard (English Version) and Makkal Kural (Tamil Version) on Saturday, the 29th Oclobet,2022. (As Per BSE Announcement Dated on 29.10.2022) Unaudited Financial Results along with Limited Review Report for the Second Quarter and Half-Year ended 30th September, 2022. Unaudited Financial Results along with Limited Review Report for the Second Quarter and Half-Year ended 30th September, 2022. (As Per BSE Announcement Dated on 31.10.2022)
09-Sep-2022	09-Sep-2022	Change in Directors	Disclosure under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No.CIR/CFD/CMD/4/ 2015 dated 9th September, 2015 - Change in Directorate
11-Jul-2022	26-Jul-2022	Quarterly Results	TTK HEALTHCARE LTD.-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/07/2022 inter alia to consider and approve the Unaudited Financial Results of the Company for the First Quarter ended 30th June 2022. Disclosure under Regulation 30 - Unaudited Financial Results along with Limited Review Report for the First Quarter ended 30th June, 2022 (As Per BSE Announcement dated on 26.07.2022) Publication of Unaudited Financial Results for the First Quarter ended 30th June, 2022 in the Newspapers - Business Standard (English) and Makkal Kural (Tamil) (As Per BSE Announcement Dated on 27.07.2022)

1 2

LOGIN HERE

TTK Healthcare Ltd

Board Meeting